This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For any practitioner-patient telemedicine relationships that have been or will be established up to November 11, 2023, the full set of telemedicine flexibilities regarding the prescription of controlled medications established during the COVID-19 PHE will be extended for one year – through November 11, 2024.
The COVID-19 pandemic has exacerbated this overdose crisis , and efforts are urgently needed to mitigate harm. Dr. Hincapie-Castillo and Dr. Goodin are Research Fellows at the Center for PublicHealth Law Research. appeared first on Bill of Health.
Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19PublicHealth Emergency, which is set to expire on May 11.
health care system, but that are especially present for behavioral health needs like substance use, and are exacerbated by other challenges related to stigma, lack of employment, and fragmented or nonexistent care coordination. This reality reflects structural, policy, and legal misalignments common to the entire U.S.
It also requires that the Secretary report to Congress on the state of the SNS, and to issue guidance and hold annual meetings with publichealth officials and stakeholders on how states, territories, and Tribes can access the SNS. Modernizes publichealth data through biosurveillance and infectious disease data collection.
The most common reason that people with an unmet need for mental health care go without it is that they cannot afford the cost of care, according to a national survey conducted by the Substance Abuse and Mental HealthServicesAdministration.
Funding for the Centers for Medicare and Medicaid Services will increase by $100 million, the National Institutes of Health will receive an additional $2.5 This will help to ensure that telehealth and hospital-at-home programs can continue to provide convenient and accessible medical treatment for patients.
Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023).
Some concerns and reasons noted by the DEA for extending the telemedicine flexibilities include: Reductions in access to care for patients who may not have an established practitioner-patient relationship; Practitioner backlogs for providing in-person medical evaluations; and Urgent publichealth needs for certain controlled medications.
News In a temporary rule, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) extended telemedicine flexibilities for prescribing controlled medications for six months following the end of the publichealth emergency, through November 11.
Prior to the federal COVID-19PublicHealth Emergency (PHE), to initiate treatment with buprenorphine at an OTP, a practitioner needed to perform a complete in-person physical evaluation. Background and History of Medicare Telehealth Coverage of SUD Treatment. Want to Learn More?
Telemedicine Prescribing During the COVID-19 PHE During the COVID-19 PHE, among many other regulatory flexibilities, federal and state prescribing requirements were relaxed. This deadline came and went, also without meaningful action taken by DEA. 21 U.S.C. § 802(17).
The high level summary below of some of the Act’s more notable components that are significant in the healthcare arena is not meant to be an exhaustive list of all health policy changes or provisions included in the Act. The Act extends certain flexibilities for Medicare coverage and payment for telehealth services through December 31, 2024.
trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. 117-164 ) (the “Act”)—an approximately $1.7
In November 2022, OCR and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) issued a Notice of Proposed Rulemaking (NPRM) which sees both Part 2 and HIPAA changes to better align these regulations. HIPAA Changes Due to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content